Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03608046
Title Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (AVETUXIRI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cliniques universitaires Saint-Luc- Universite Catholique de Louvain

colorectal adenocarcinoma


Avelumab + Cetuximab + Irinotecan

Age Groups: adult | senior
Covered Countries BEL

Facility Status City State Zip Country Details
Cliniques Universitaires Saint-Luc Recruiting Brussels 1200 Belgium Details
Grand Hôpital de Charleroi Recruiting Charleroi 6000 Belgium Details
*Shaded cells indicate that there was no data available from for the field